Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

SHE:002653 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 1, 2025	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	44,858	25,545	23,695	21,747	18,638	21,777
Market Cap Growth	59.17%	7.81%	8.96%	16.68%	-14.41%	71.24%
Enterprise Value	45,634	26,256	25,227	22,521	19,066	22,271
Last Close Price	40.44	22.80	21.91	19.86	16.82	19.47
PE Ratio	93.60	86.56	85.52	63.02	29.28	44.09
Forward PE	70.79	62.99	69.53	62.77	23.76	44.73
PS Ratio	11.97	7.61	7.86	7.84	5.60	5.53
PB Ratio	10.96	6.13	7.56	7.45	6.53	9.16
P/TBV Ratio	13.91	7.45	10.18	10.07	8.10	10.62
P/FCF Ratio	463.38	436.15	-	-	-	119.93
P/OCF Ratio	79.51	56.82	250.62	607.43	90.39	28.50
EV/Sales Ratio	12.26	7.83	8.37	8.12	5.73	5.66
EV/EBITDA Ratio	73.34	52.01	79.50	122.44	57.27	54.20
EV/EBIT Ratio	120.09	89.00	178.20	598.98	83.50	68.95
EV/FCF Ratio	471.39	448.29	-	-	-	122.65
Debt / Equity Ratio	0.50	0.43	0.67	0.43	0.38	0.45
Debt / EBITDA Ratio	3.33	3.53	6.48	6.55	3.23	2.63
Debt / FCF Ratio	21.42	30.84	-	-	-	5.95
Asset Turnover	0.57	0.53	0.55	0.56	0.66	0.84
Inventory Turnover	3.50	3.10	3.05	3.91	5.17	7.98
Quick Ratio	1.72	1.50	1.09	0.81	1.04	0.73
Current Ratio	1.99	1.76	1.38	1.02	1.22	0.83
Return on Equity (ROE)	13.22%	8.09%	12.94%	17.93%	22.98%	21.73%
Return on Assets (ROA)	3.62%	2.90%	1.60%	0.47%	2.84%	4.29%
Return on Capital (ROIC)	3.98%	3.29%	1.88%	0.58%	3.86%	6.32%
Return on Capital Employed (ROCE)	7.00%	5.70%	3.10%	1.10%	7.00%	12.70%
Earnings Yield	1.06%	1.16%	1.17%	1.59%	3.42%	2.27%
FCF Yield	0.22%	0.23%	-2.56%	-3.07%	-2.12%	0.83%
Dividend Yield	0.65%	0.88%	-	0.93%	2.21%	0.47%
Payout Ratio	88.72%	14.43%	89.32%	123.52%	20.54%	48.35%
Buyback Yield / Dilution	-1.13%	-2.57%	1.17%	0.07%	-0.50%	0.12%
Total Shareholder Return	-0.48%	-1.69%	1.17%	1.00%	1.71%	0.59%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.